Added to YB: 2015-10-08
Pitch date: 2015-10-08
GBT:US [bullish]
Global Blood Therapeutics, Inc.
+72.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Global Blood Therapeutics, Inc., a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat grievous blood-based disorders.
Market Cap
$4.6B
Pitch Price
$39.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
-16.29
P/E
-13.69
EV/Sales
19.65
Sector
Biotechnology
Category
N/A
Show full summary:
Global Blood Therapeutics Inc GBT:US
A summary for this pitch has not been created yet.
Read full article (0 min)